13F HOLDINGS REPORT
Aquilo Capital Management, LLC
Quarter ended Q3 2023 · Filed August 14, 2023 · Accession 0001591986-23-000007
Total Value
$180.5M
Positions
13
Other Managers
0
Confidential Omitted
No
Holdings (13)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ARROWHEAD PHARMACEUTICALS IN | ARWR | 858,474 | $30.6M | 16.96% |
| 2 | BLUEPRINT MEDICINES CORP | 09627Y109 | 448,987 | $28.4M | 15.72% |
| 3 | ISHARES RUSSELL 2000 ETF TR | 464287655 | 150,000 | $28.1M | 15.57% |
| 4 | MERUS N V | N5749R100 | 775,109 | $20.4M | 11.31% |
| 5 | REGENXBIO INC | RGNX | 870,114 | $17.4M | 9.64% |
| 6 | ARVINAS INC | ARVN | 623,941 | $15.5M | 8.58% |
| 7 | KYMERA THERAPEUTICS INC | KYMR | 651,325 | $15.0M | 8.30% |
| 8 | SILENCE THERAPEUTICS PLC | SLNCF | 1,312,233 | $7.2M | 4.00% |
| 9 | GENMAB A/S | GNMSF | 174,648 | $6.6M | 3.68% |
| 10 | ARGENX SE | ARGX | 16,315 | $6.4M | 3.52% |
| 11 | OLEMA PHARMACEUTICALS INC | OLMA | 250,000 | $2.3M | 1.25% |
| 12 | C4 THERAPEUTICS INC | CCCC | 760,657 | $2.1M | 1.16% |
| 13 | PIERIS PHARMACEUTICALS INC | 720795103 | 3,303,190 | $546,678 | 0.30% |